Navigation Links
Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment
Date:5/23/2013

BUSAN, South Korea, May 23, 2013 /PRNewswire/ -- Pusan National University Yangsan Hospital, in collaboration with SillaJen, Inc., a private biotherapeutics and contract research company focused on research and development of targeted biological products for cancer, announced today a publication reporting the induction of functional anti-cancer antibodies in patients treated with the oncolytic and immunotherapeutic vaccinia JX-594 (pexastimogene devacirepvec; Jennerex Inc.).

This research was published in the May 15th, 2013 issue of the journal Science Translational Medicine. The co-senior and co-corresponding authors were Dr. Tae-Ho Hwang (Director of the Pusan National University Yangsan Hospital Clinical Research Center; SillaJen Chief Scientific Officer) and Dr. David Kirn (Jennerex founder and Advisor to SillaJen). The authors reported data from patients treated with JX-594 on Phase 1 and 2 clinical trials, as well as from rabbit tumor model studies. The authors demonstrated functional anti-cancer immunity induction, specifically including antibody-mediated complement-dependent cytotoxicity (CDC) in patients' serum targeting cancer cells.  Phase 1 data showed a correlation between patients' survival duration and a measure of CDC intensity. No autoimmune toxicities were reported in treated patients, including long-term survivors.

"This research was led by the laboratory group at SillaJen and Pusan National University, working closely with scientists at Jennerex. These findings, published in the premier research journal Science Translational Medicine, represent a landmark for the field of oncolytic immunotherapies for cancer," said Dr. Tae-Ho Hwang . "We were able to demonstrate for the first time that functional immune responses were induced against cancer cells following JX-594 treatment. T
'/>"/>

SOURCE Pusan National University
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. First Evidence that Adipose Stem Cell-Based Critical Limb Ischemia Treatment is Safe & Effective is published in Circulation Journal by Lead Investigator Dr. Han Cheol Lee of Pusan National University
2. UV Flu Technologies Expands Its International Footprint
3. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
4. International Attendance for Networking and Education at Informex Beyond Manufacturing
5. Sundberg Kicks Off National Expansion With Openings of New Headquarters, Logistically Centric Mega Warehouses
6. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
7. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
8. First Free-Standing International Mesothelioma Research Laboratory Opens in Los Angeles
9. Cord Blood America Announces Exclusive Agreement With National Childrens Leukemia Foundation to Store Stem Cells
10. PAREXEL International to Present at J.P. Morgan Healthcare Conference
11. DFH Pharma to Collaborate With National Cancer Institute to Develop Second-Generation HIV Maturation Inhibitor Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)...  Spherix Incorporated (SPEX) -- an intellectual property development company committed ... announced that the United States Patent & Trademark Office ... month of August that are part of a standard ... patents are: , U.S.RE45,065 issued August ... and , U.S.RE45,095 issued August 26, 2014.  ...
(Date:9/1/2014)... The global oligonucleotide synthesis market is expected ... million in 2014, growing at a CAGR of ... synthesis market is categorized on the basis of ... The synthesized oligonucleotides segment is expected to register ... market during the forecast period, owing to an ...
(Date:8/31/2014)... August 31, 2014 2014 ... is a professional and in-depth research report ... basic Polyacrylamide information, including Polyacrylamide definition, classification, ... as industry overview. This research covers the ... well as global industry analysis covering macroeconomic ...
(Date:8/29/2014)... but one of the most promising technologies for future ... light (photons) instead of electrons. First, it is necessary ... photons and control their direction. Researchers around the world ... control, but now scientists at the Niels Bohr Institute ... emitted one at a time and in a particular ...
Breaking Biology Technology:United States Patent & Trademark Office Issues Three New Standard Essential Patents to Spherix 29.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com 29.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com 39.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com 49.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com 5International Polyacrylamide Industry & Copper Iodide Market Data Analysis Now Available at DeepResearchReports.com 2International Polyacrylamide Industry & Copper Iodide Market Data Analysis Now Available at DeepResearchReports.com 3Breakthrough in light sources for new quantum technology 2
... AC Immune SA, a leader,in Alzheimer,s disease drug development, ... Immune as Technology Pioneer 2009 for its,accomplishments as an ... a deep impact on business and society. , ... that it has reached significant clinical,milestones in the development ...
... A 60-year-old,prostate cancer patient from Montpellier has become ... RapidArc(TM) technology from Varian Medical Systems,(NYSE: ... intensity modulated radiotherapy,(IMRT). Each of his treatments at ... city took just 75 seconds, several times faster ...
... Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that it ... year 2009 on December 10, 2008 at 7:00 a.m. EST and ... at 11:30 a.m. EST on the same day. , ... results for the second quarter ended October 31, 2008 and will ...
Cached Biology Technology:Technology Pioneer 2009 - AC Immune Highlights Significant Clinical Milestones in Alzheimer's Disease Drug Development 2Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varian's RapidArc(TM) Radiotherapy 2Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varian's RapidArc(TM) Radiotherapy 3Peregrine Pharmaceuticals to Report Second Quarter FY 2009 Financial Results 2
(Date:9/2/2014)... New research suggests that professional baseball pitchers with poor ... days in a single season because of injury than are ... back and pelvis. , In the study, 347 pitchers were ... tilt in their pelvis as they raised a leg to ... miss at least 30 days cumulative, not consecutive ...
(Date:9/2/2014)... the University of Warwick in the UK and the ... Journal Early Human Development , has found that ... birth and the use of mechanical ventilation are key ... Mathematic abilities are crucial for lifelong academic attainment. Impairments ... Earlier studies of children who are born very preterm ...
(Date:9/2/2014)... the most ideal source of nutrition for infants ... in the evolution and civilizations of human beings. ... large number of bacterial species, including some opportunistic ... surprise to scientists and physicians. , Indeed, the ... the result of co-evolutionary and co-adaptive interactions between ...
Breaking Biology News(10 mins):In pro baseball pitchers, weak core linked to more missed days 2In pro baseball pitchers, weak core linked to more missed days 3Mechanical ventilation a key indicator for pre-term children's math problems 2Are human breast milk microbiome 'neutral'? 2Are human breast milk microbiome 'neutral'? 3
... on labor-intensive microscopic examination, using century-old cell-staining ... and may give false readings. , A ... Laboratories researcher Paul Gourley, has provided laboratory ... liver tumor cells at their earliest stages, ...
... Canadian Network for Vaccines and Immunotherapeutics, has announced,the ... well the thymus (an organ,located at the base ... a,functional abnormality of this organ in HIV-infected individuals. ... professor at,Université de Montréal, scientist at the CHUM ...
... used to synthesize plastic food containers has been ... of prostate cancer cell,potentially affecting the treatment efficacy ... published in the January 1 issue of Cancer,Research, ... to,exposure to the chemical BPA (bisophenol A), an ...
Cached Biology News:Novel ultrafast laser detection of cancer cells also may improve understanding of stem cells 2Novel ultrafast laser detection of cancer cells also may improve understanding of stem cells 3Estrogen-like Component of Plastic Stimulates Growth of Certain Prostate Cancer Cells 2